Curis Inc Employee Directory
Pharmaceutical ManufacturingMassachusetts, United States2-10 Employees
Curis Inc is a small biotechnology company focused on drug development in oncology, aiming to create targeted small-molecule cancer therapies by leveraging signaling pathway drug technologies. Based in Cambridge, Massachusetts, the company operates in the pharmaceutical development space. Its lead program, emavusertib (CA-4948), is an orally available inhibitor developed to target IRAK4 and is advancing in clinical studies for frontline acute myeloid leukemia and related cancers. In December 2025, Curis reported updated clinical data from the frontline AML triplet study CA-4948-104 at the ASH Annual Meeting, reflecting ongoing clinical activity.